volume 17 issue 10 pages 2579-2593

Photoimmunoconjugates: novel synthetic strategies to target and treat cancer by photodynamic therapy

Sara R G Fernandes 1, 2, 3, 4, 5, 6, 7, 8
Rosa Fernandes 9, 10, 11, 12, 13, 14, 15
Bruno Sarmento 2, 3, 15, 16, 17, 18, 19, 20
Patrícia Matos Pereira 21
Patrícia M.R. Pereira 22, 23, 24, 25
Joao Paulo Costa Tome 1, 4, 5, 6, 7, 8
Publication typeJournal Article
Publication date2019-01-08
scimago Q2
wos Q2
SJR0.600
CiteScore5.2
Impact factor2.7
ISSN14770520, 14770539
PubMed ID:  30648722
Organic Chemistry
Biochemistry
Physical and Theoretical Chemistry
Abstract
Photodynamic therapy (PDT) combines a photosensitizer (PS) with the physical energy of non-ionizing light to trigger cell death pathways. PDT has potential as a therapeutic modality to be used in alternative or in combination with other conventional cancer treatment protocols (e.g. surgery, chemotherapy and radiotherapy). Still, due to the lack of specificity of the current PSs to target the tumor cells, several studies have exploited their conjugation with targeting moieties. PSs conjugated with antibodies (Abs) or their fragments, able to bind antigens overexpressed in the tumors, have demonstrated potential in PDT of tumors. This review provides an overview of the most recent advances on photoimmunoconjugates (PICs) for cancer PDT, which involve the first and second-generation PSs conjugated to Abs. This is an update of our previous review “Antibodies armed with photosensitizers: from chemical synthesis to photobiological applications”, published in 2015 in Org. Biomol. Chem.
Found 
Found 

Top-30

Journals

1
2
3
4
Pharmaceutics
4 publications, 6.35%
Dyes and Pigments
4 publications, 6.35%
Journal of Clinical Medicine
3 publications, 4.76%
European Journal of Medicinal Chemistry
3 publications, 4.76%
International Journal of Molecular Sciences
2 publications, 3.17%
Applied Organometallic Chemistry
2 publications, 3.17%
Journal of Medicinal Chemistry
2 publications, 3.17%
Molecular Pharmaceutics
2 publications, 3.17%
Nanophotonics
2 publications, 3.17%
Biomolecular Concepts
2 publications, 3.17%
Biomedicine and Pharmacotherapy
2 publications, 3.17%
Applied Physics Reviews
1 publication, 1.59%
World Journal of Gastrointestinal Surgery
1 publication, 1.59%
Cancers
1 publication, 1.59%
Molecules
1 publication, 1.59%
Frontiers in Oncology
1 publication, 1.59%
Frontiers in Chemistry
1 publication, 1.59%
Pharmaceuticals
1 publication, 1.59%
Nature Communications
1 publication, 1.59%
AAPS PharmSciTech
1 publication, 1.59%
Photodiagnosis and Photodynamic Therapy
1 publication, 1.59%
European Journal of Medicinal Chemistry Reports
1 publication, 1.59%
International Journal of Biochemistry and Cell Biology
1 publication, 1.59%
Journal of Photochemistry and Photobiology B: Biology
1 publication, 1.59%
Polyhedron
1 publication, 1.59%
Veterinary Microbiology
1 publication, 1.59%
Nanomedicine: Nanotechnology, Biology, and Medicine
1 publication, 1.59%
Inorganica Chimica Acta
1 publication, 1.59%
Photochemistry and Photobiology
1 publication, 1.59%
Advanced Functional Materials
1 publication, 1.59%
1
2
3
4

Publishers

5
10
15
20
25
Elsevier
22 publications, 34.92%
MDPI
13 publications, 20.63%
Wiley
5 publications, 7.94%
American Chemical Society (ACS)
5 publications, 7.94%
Springer Nature
4 publications, 6.35%
Walter de Gruyter
4 publications, 6.35%
Frontiers Media S.A.
2 publications, 3.17%
Pleiades Publishing
2 publications, 3.17%
AIP Publishing
1 publication, 1.59%
Baishideng Publishing Group
1 publication, 1.59%
Ivanovo State University of Chemistry and Technology
1 publication, 1.59%
Royal Society of Chemistry (RSC)
1 publication, 1.59%
OOO Zhurnal "Mendeleevskie Soobshcheniya"
1 publication, 1.59%
Taylor & Francis
1 publication, 1.59%
5
10
15
20
25
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
63
Share
Cite this
GOST |
Cite this
GOST Copy
Fernandes S. R. G. et al. Photoimmunoconjugates: novel synthetic strategies to target and treat cancer by photodynamic therapy // Organic and Biomolecular Chemistry. 2019. Vol. 17. No. 10. pp. 2579-2593.
GOST all authors (up to 50) Copy
Fernandes S. R. G., Fernandes R., Sarmento B., Pereira P. M., Pereira P. M., Tome J. P. C. Photoimmunoconjugates: novel synthetic strategies to target and treat cancer by photodynamic therapy // Organic and Biomolecular Chemistry. 2019. Vol. 17. No. 10. pp. 2579-2593.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1039/c8ob02902d
UR - https://xlink.rsc.org/?DOI=C8OB02902D
TI - Photoimmunoconjugates: novel synthetic strategies to target and treat cancer by photodynamic therapy
T2 - Organic and Biomolecular Chemistry
AU - Fernandes, Sara R G
AU - Fernandes, Rosa
AU - Sarmento, Bruno
AU - Pereira, Patrícia Matos
AU - Pereira, Patrícia M.R.
AU - Tome, Joao Paulo Costa
PY - 2019
DA - 2019/01/08
PB - Royal Society of Chemistry (RSC)
SP - 2579-2593
IS - 10
VL - 17
PMID - 30648722
SN - 1477-0520
SN - 1477-0539
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2019_Fernandes,
author = {Sara R G Fernandes and Rosa Fernandes and Bruno Sarmento and Patrícia Matos Pereira and Patrícia M.R. Pereira and Joao Paulo Costa Tome},
title = {Photoimmunoconjugates: novel synthetic strategies to target and treat cancer by photodynamic therapy},
journal = {Organic and Biomolecular Chemistry},
year = {2019},
volume = {17},
publisher = {Royal Society of Chemistry (RSC)},
month = {jan},
url = {https://xlink.rsc.org/?DOI=C8OB02902D},
number = {10},
pages = {2579--2593},
doi = {10.1039/c8ob02902d}
}
MLA
Cite this
MLA Copy
Fernandes, Sara R. G., et al. “Photoimmunoconjugates: novel synthetic strategies to target and treat cancer by photodynamic therapy.” Organic and Biomolecular Chemistry, vol. 17, no. 10, Jan. 2019, pp. 2579-2593. https://xlink.rsc.org/?DOI=C8OB02902D.